Condition: Primary Immune Thrombocytopenia (ITP) · Sponsor: Grand Shuyang Life Sciences (Chengdu) Co., Ltd.
It is a clinical trial of a medicinal product Human Immunoglobulin for Intravenous Injection (5%) manufactured by Grand Shuyang Life Sciences (Chengdu) Co., Ltd. (hereinafter referred to as 5% IVIG). This clinical study is conducted to evaluate the efficacy and safety of 5% IVIG in patients with primary Immune Thrombocytopenia (ITP). The study includes 4 periods and 9 visits (designated as V): * Screening period (V1: 14 days before the first administration, preliminary examination); * Baseline Period (V2: within 24 h before the first dose, Day 0); * Treatment Period (V3: Day 1 to Day 5, administration of the drug in a hospital setting); * Follow-up Period (V4-V9: visits to Study Site on Day 6, Day 7, Day 14 + 2, Day 21 + 3, Day 28 + 4, and Day 90 (+ 14) after the first dose). In this study, the investigational product 5% IVIG will be administered at a dose of 0.4 g/kg/day (direct intravenous drip) for 5 consecutive days. The total duration of your participation in the study will be approximately 104 days. The investigational product will only be provided during the study period. It will not be supplied after the study ends. The study will be conducted at clinical centers in Turkey. It is planned to obtain data from 36 patients included in the study (no more than 48 screened patients).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Hacettepe University Faculty of Medicine | Ankara, Altındağ, Turkey (Türkiye) | Recruiting |
| İnönü University Turgut Ozal Medical Center Training and Research Hospital | Malatya, Battalgazi, Turkey (Türkiye) | Recruiting |
| İstanbul University, Istanbul Faculty of Medicine | Istanbul, Fatih, Turkey (Türkiye) | Recruiting |
| Erciyes University Hematology Hospital | Kayseri, Melikgazi, Turkey (Türkiye) | Recruiting |
| VM Medical Park Mersin | Mersin, Mezitli, Turkey (Türkiye) | Recruiting |
| Antalya Training and Research Hospital | Antalya, Muratpaşa, Turkey (Türkiye) | Recruiting |
| Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi | Ankara, Yenimahalle, Turkey (Türkiye) | Recruiting |
| Adana City Education and Research Hospital, Hematology Department | Adana, Yüreğir, Turkey (Türkiye) | Recruiting |
| Gaziantep University Şahinbey Training and Research Hospital | Gaziantep, Şehitkamil, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07233213